These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils. Ohmori K, Manabe H, Akuta-Ohnuma K. Arzneimittelforschung; 1998 Jan; 48(1):43-6. PubMed ID: 9522030 [Abstract] [Full Text] [Related]
11. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs. Tohda Y, Nakajima S, Shizawa T, Maeda K, Ohmori S, Satoh H, Ishii T, Kamitani T. Clin Exp Allergy; 1997 Jan; 27(1):110-8. PubMed ID: 9117875 [Abstract] [Full Text] [Related]
12. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells. Amon U, Gibbs BF, Buss G, Nitschke M. Inflamm Res; 2000 Mar; 49(3):112-6. PubMed ID: 10807498 [Abstract] [Full Text] [Related]
13. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events. Fretland DJ, Anglin CP, Bremer M, Isakson P, Widomski DL, Paulson SK, Docter SH, Djuric SW, Penning TD, Yu S. Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505 [Abstract] [Full Text] [Related]
14. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative. Fukuda S, Midoro K, Yamasaki M, Gyoten M, Kawano Y, Fukui H, Ashida Y, Nagaya H. Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625 [Abstract] [Full Text] [Related]
15. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes. Mita H, Shida T. Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266 [Abstract] [Full Text] [Related]
16. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine. Tasaka K, Kamei C, Izushi K, Tsujimoto S, Yoshida T. Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277 [Abstract] [Full Text] [Related]
17. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. Matsushita N, Aritake K, Takada A, Hizue M, Hayashi K, Mitsui K, Hayashi M, Hirotsu I, Kimura Y, Tani T, Nakajima H. Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057 [Abstract] [Full Text] [Related]
18. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis. Fretland DJ, Widomski DL, Zemaitis JM, Djurić SW, Shone RL. Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605 [Abstract] [Full Text] [Related]
19. Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro. Dupont LJ, Pype JL, Meade CJ, DeLeyn P, Deneffe G, Demedts MG, Verleden GM. Eur Respir J; 1999 Nov; 14(5):1068-75. PubMed ID: 10596692 [Abstract] [Full Text] [Related]
20. Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor. Dupont LJ, Meade CJ, Demedts MG, Verleden GM. Eur Respir J; 1996 Jul; 9(7):1433-8. PubMed ID: 8836655 [Abstract] [Full Text] [Related] Page: [Next] [New Search]